Advanced Chronic Weight Management: Serves as a vital progressive tier to intensify adipose tissue reduction and lock in long-term body contouring
Vision loss can reduce mobility, confidence, activity, and cognitive stimulation
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors
Your GP or diabetes specialist should: Evaluate whether symptoms coincide with dose escalation (suggesting a possible connection to treatment) Review all concurrent medications for potential contributors Assess for alternative causes, particularly thyroid function and menopausal status in women Consider whether glycaemic control has changed significantly Review insulin or sulfonylurea doses if hypoglycaemia is suspected For women experiencing menopausal hot flushes, hormone replacement therapy (HRT) is generally considered first-line treatment where appropriate, in line with NICE guidance
Moreover, the impact of semaglutide extends beyond your digestive system
Severe nausea leads to skipped doses